Pituitary function after moderate or severe traumatic brain injury in two pediatric reference centers in Bogotá D.C,

William Javier Morales Camacho1, Shokery Salied Awadalla Gabrial2, Claudia Irene Ibáñez3

  • 1University Foundation of Health Sciences (FUCS) - Sociedad de Cirugía de Bogotá - Hospital de San José, Bogotá, D.C., Colombia. wjmorales@fucsalud.edu.co.

PubMed

Insights

Hypopituitarism (HPPT) occurred in 5.66% of pediatric patients after moderate or severe traumatic brain injury (TBI). Growth hormone deficiency was the only identified endocrine alteration, emphasizing the need for long-term pituitary monitoring.

Area of Science:

  • Pediatric Endocrinology
  • Neurotraumatology
  • Pediatric Critical Care

Background:

  • Traumatic brain injury (TBI) is a significant cause of childhood morbidity and mortality globally.
  • Hypopituitarism (HPPT) is a potential long-term complication of moderate or severe TBI in children, with reported prevalence rates varying widely.
  • Growth hormone deficiency (GHD) is the most common endocrine abnormality in the chronic phase following pediatric TBI.

Purpose of the Study:

  • To assess pituitary function in pediatric patients following moderate or severe TBI.
  • To determine the prevalence of hypopituitarism in this cohort.
  • To provide the first systematic evaluation of pituitary function post-TBI in a Colombian pediatric population.

Main Methods:

  • A cohort of 53 pediatric patients (23 moderate TBI, 30 severe TBI) was studied.
  • Pituitary hormone levels (TSH, FT4, IGF-1, cortisol, prolactin) were measured at least 6 months post-TBI.
  • Growth hormone deficiency (GHD) was diagnosed based on IGF-1 levels and confirmed with dynamic stimulation testing.

Main Results:

  • Hypopituitarism was identified in 3 out of 53 patients (5.66%).
  • All identified cases of hypopituitarism were exclusively growth hormone deficiency (GHD).
  • Two patients with GHD had experienced severe TBI; no other pituitary axes showed clinically significant abnormalities.

Conclusions:

  • Hypopituitarism affects a small proportion of pediatric patients in the chronic phase after moderate or severe TBI.
  • These findings underscore the importance of targeted endocrine evaluations for long-term follow-up.
  • Structured pituitary monitoring is crucial for improving outcomes in pediatric TBI survivors.